Jenny Klinger, CPA

Jenny Klinger, CPA, has extensive work experience in financial planning and analysis, with a focus on the pharmaceutical and healthcare industries. Jenny is currently the Head of Financial Planning and Analysis at Disc Medicine, a position they have held since November 2021. Previously, they held roles at Seres Therapeutics as a Senior Director and later as a Director of Financial Planning and Analysis from an unknown start date to October 2021. Jenny also worked at Sanofi Genzyme as an Associate Director of US and Global Forecasting from 2017 to 2019. Prior to that, they held positions at Epizyme and FORUM Pharmaceuticals as a Senior Finance Manager and Financial Reporting Manager, respectively. Jenny began their career at Biogen as a Senior Financial Analyst - US Commercial and then moved on to Partners HealthCare as a Senior Accounting Analyst. Jenny also gained experience at Goldman Sachs and KPMG US as an Analyst and Associate in their respective finance divisions.

Jenny Klinger, CPA has an impressive education history, with a particular focus on accounting and finance. Jenny completed their Master of Business Administration degree at Northwestern University - Kellogg School of Management from 2017 to 2018. Prior to that, they obtained a Master of Science degree in Accountancy from the University of Illinois Urbana-Champaign, which they completed from 2005 to 2006.

Jenny's undergraduate studies were completed at Providence College, where they earned a Bachelor of Arts degree in Economics and Finance from 2001 to 2005. Before their college years, they attended St. Ignatius College Prep from 1997 to 2001, although no specific degree or field of study is mentioned for this period.

In addition to their educational achievements, Jenny is also a Certified Public Accountant (CPA) certified by The American Institute of Certified Public Accountants (AICPA). The exact year and month of obtaining this certification are not provided.